On December 10th, 2020, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC or the Committee) hold a meeting to evaluate the Pfizer-BioNTech vaccine for the COVID-19.
This article provides a critical review of the underlying scientific aspect of the evaluation process and its outcome. The Committee’s judgment is considered biased, lacking scientific vigor – including for chemistry and manufacturing, and misleading for describing efficacy and safety assessment for the vaccine use. Continue here